Screening differentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis

World Journal of Gastroenterology

Volumn 11, Issue 12, 2005, Pages 1837-1842

  Cui, Xiao Nan ^a   Tang, Jian Wu ^a   Hou, Li ^a   Song, Bo ^a   Li, Li ^a   Liu, Ji Wei ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Liver neoplasm; Lymphogenous metastasis; Suppression subtracted hybridization

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; ASCITES CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DNA LIBRARY; GENBANK; GENE EXPRESSION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; SEQUENCE HOMOLOGY; SUPPRESSION SUBTRACTIVE HYBRIDIZATION;

EID: 17144399215     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i12.1837     Document Type: Article

References (32)

1. Ji Y, Ling MY, Li Y, Xie H. Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines. World J Gastroenterol 1999; 5: 22-24
2. Diatchenko L, Lukyanov S, Lau YF, Siebert PD. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol 1999; 303: 349-380
3. von Stein OD, Thies WG, Hofmann M. A high throughout screening for rarely transcribed differentially expressed genes. Nucleic Acids Res 1997; 25: 2598-2602
4. Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery 2003; 133: 300-308
5. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 2002; 99: 8868-8873
6. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98: 12677-12682
7. Yonemura Y, Fushida S, Bando E, Kinoshita K, Miwa K, Endo Y, Sugiyama K, Partanen T, Yamamoto H, Sasaki T. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 2001; 37: 918-923
8. Tille JC, Nisato R, Pepper MS. Lymphangiogenesis and tumour metastasis. Clin Cancer Res 2001; 7: 462-468
9. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001; 61: 1786-1790
10. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000; 19: 5598-5605
11. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003; 97: 457-464
12. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-198
13. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, Sugimachi K. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000; 83: 887-891
14. Kabashima A, Maehara Y, Kakeji Y, Sugimachi K. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 2001; 60: 146-150
15. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics: Authors' correction. Trends Cell Biol 1999; 9: 187-192
16. Scherer SS, Xu T, Crino P, Arroyo EJ, Gutmann DH. Ezrin, radixin, and moesin are components of Schwann cell microvilli. J Neurosci Res 2001; 65: 150-164
17. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikuchi A, Yamamoto T, Satoh K, Naftolin F. Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 1999; 147: 31-38
18. Makitie T, Carpen O, Vaheri A, Kivela T. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001; 42: 2442-2449
19. Gautreau A, Poullet P, Louvard D, Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/ Akt pathway. Proc Natl Acad Sci USA 1999; 96: 7300-7305
20. Geiger KD, Stoldt P, Schlote W, Derouiche A. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000; 157: 1785-1793
21. Akisawa N, Nishimori I, Iwamura T, Onishi S, Hollingsworth MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999; 258: 395-400
22. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W. Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma. Ann Thorac Surg 2002; 74: 222-226
23. Kapranos N, Kominea A, Konstantinopoulos PA, Savva S, Vandoros G, Sotiropoulou-Bonikou G, Papavassiliou AG. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 2002; 128: 426-432
24. Piselli P, Vendetti S, Vismara D, Cicconi R, Poccia F, Delpino A. Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice. Anticancer Res 2000; 20: 825-831
25. Barnard GF, Staniunas RJ, Bao S, Mafune K, Steele GD Jr, Gollan JL, Chen LB. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. Cancer Res 1992; 52: 3067-3072
26. Denis MG, Chadeneau C, Lecabellec MT, LeMoullac B, LeMevel B, Meflah K, Lustenberger P. Over-expression of the S13 ribosomal protein in actively growing cells. In J Cancer 1993; 35: 275-280
27. Chadeneau C, LeMoullac B, Denis MG. Cloning and analysis of the human S13 ribosomal protein CDNA. Nucleic Acids Res 1993; 21: 2945
28. Kondoh N, Schweinfest CW, Henderson KW, Papas TS. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 1992; 52: 791-796
29. Brooks RF. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 1977; 12 311-317
30. Thomas G, Martin-Perez J, Siegmann M, Otto AM. The effect of serum, EGF, PGF2 a and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell 1982; 30: 235-242
31. Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol Cell Biol 2004; 24: 3025-3035
32. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF. Complementary DNA sequencing: expressed sequence tag sand human genome project. Science 1991; 252: 1651-1656